These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 23787997)

  • 1. Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8.
    Sukkurwala AQ; Martins I; Wang Y; Schlemmer F; Ruckenstuhl C; Durchschlag M; Michaud M; Senovilla L; Sistigu A; Ma Y; Vacchelli E; Sulpice E; Gidrol X; Zitvogel L; Madeo F; Galluzzi L; Kepp O; Kroemer G
    Cell Death Differ; 2014 Jan; 21(1):59-68. PubMed ID: 23787997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
    Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
    Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors.
    Joseph PR; Sarmiento JM; Mishra AK; Das ST; Garofalo RP; Navarro J; Rajarathnam K
    J Biol Chem; 2010 Sep; 285(38):29262-9. PubMed ID: 20630874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases.
    Russo RC; Garcia CC; Teixeira MM; Amaral FA
    Expert Rev Clin Immunol; 2014 May; 10(5):593-619. PubMed ID: 24678812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phylogenetic conservation of the preapoptotic calreticulin exposure pathway from yeast to mammals.
    Madeo F; Durchschlag M; Kepp O; Panaretakis T; Zitvogel L; Fröhlich KU; Kroemer G
    Cell Cycle; 2009 Feb; 8(4):639-42. PubMed ID: 19182525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-derived CXCL8 signaling augments stroma-derived CCL2-promoted proliferation and CXCL12-mediated invasion of PTEN-deficient prostate cancer cells.
    Maxwell PJ; Neisen J; Messenger J; Waugh DJ
    Oncotarget; 2014 Jul; 5(13):4895-908. PubMed ID: 24970800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constitutive and treatment-induced CXCL8-signalling selectively modulates the efficacy of anti-metabolite therapeutics in metastatic prostate cancer.
    Wilson C; Maxwell PJ; Longley DB; Wilson RH; Johnston PG; Waugh DJ
    PLoS One; 2012; 7(5):e36545. PubMed ID: 22590561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death.
    Panaretakis T; Joza N; Modjtahedi N; Tesniere A; Vitale I; Durchschlag M; Fimia GM; Kepp O; Piacentini M; Froehlich KU; van Endert P; Zitvogel L; Madeo F; Kroemer G
    Cell Death Differ; 2008 Sep; 15(9):1499-509. PubMed ID: 18464797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression.
    Gabellini C; Trisciuoglio D; Desideri M; Candiloro A; Ragazzoni Y; Orlandi A; Zupi G; Del Bufalo D
    Eur J Cancer; 2009 Sep; 45(14):2618-27. PubMed ID: 19683430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nerve growth factor alters calreticulin translocation from the endoplasmic reticulum to the cell surface and its signaling pathway in epithelial ovarian cancer cells.
    Vera CA; Oróstica L; Gabler F; Ferreira A; Selman A; Vega M; Romero CA
    Int J Oncol; 2017 Apr; 50(4):1261-1270. PubMed ID: 28260038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer.
    Li E; Yang X; Du Y; Wang G; Chan DW; Wu D; Xu P; Ni P; Xu D; Hu Y
    Front Immunol; 2021; 12():667177. PubMed ID: 34025668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biphasic Increases of Cell Surface Calreticulin Following Treatment with Mitoxantrone.
    Azuma Y; Suzuki K; Higai K; Matsumoto K; Tada S
    Biol Pharm Bull; 2020 Oct; 43(10):1595-1599. PubMed ID: 32727970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An updated review on the role of the CXCL8-CXCR1/2 axis in the progression and metastasis of breast cancer.
    Mishra A; Suman KH; Nair N; Majeed J; Tripathi V
    Mol Biol Rep; 2021 Sep; 48(9):6551-6561. PubMed ID: 34426905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist.
    Gonsiorek W; Fan X; Hesk D; Fossetta J; Qiu H; Jakway J; Billah M; Dwyer M; Chao J; Deno G; Taveras A; Lundell DJ; Hipkin RW
    J Pharmacol Exp Ther; 2007 Aug; 322(2):477-85. PubMed ID: 17496166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probiotics improve re-epithelialization of scratches infected by Porphyromonas gingivalis through up-regulating CXCL8-CXCR1/CXCR2 axis.
    Albuquerque-Souza E; Ishikawa KH; Amado PP; Nicoli JR; Holzhausen M; Mayer MPA
    Anaerobe; 2021 Dec; 72():102458. PubMed ID: 34547426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CXCL8-CXCR1/2 pathways in cancer.
    Liu Q; Li A; Tian Y; Wu JD; Liu Y; Li T; Chen Y; Han X; Wu K
    Cytokine Growth Factor Rev; 2016 Oct; 31():61-71. PubMed ID: 27578214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma.
    Maxwell PJ; Coulter J; Walker SM; McKechnie M; Neisen J; McCabe N; Kennedy RD; Salto-Tellez M; Albanese C; Waugh DJ
    Eur Urol; 2013 Aug; 64(2):177-88. PubMed ID: 22939387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERP57 membrane translocation dictates the immunogenicity of tumor cell death by controlling the membrane translocation of calreticulin.
    Obeid M
    J Immunol; 2008 Aug; 181(4):2533-43. PubMed ID: 18684944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antagonist of CXCR1 and CXCR2 protects
    Cui S; Qiao L; Yu S; Men L; Li Y; Li F; Du J
    Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1205-E1217. PubMed ID: 31573846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The key role of calreticulin in immunomodulation induced by chemotherapeutic agents.
    Yamamura Y; Tsuchikawa T; Miyauchi K; Takeuchi S; Wada M; Kuwatani T; Kyogoku N; Kuroda A; Maki T; Shichinohe T; Hirano S
    Int J Clin Oncol; 2015 Apr; 20(2):386-94. PubMed ID: 24972573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.